Cell Impact (OSTO:CI) Total Liabilities: kr25.98 Mil (As of Mar. 2026)


What is Cell Impact Total Liabilities?

Cell Impact OSTO:CI -1.66% Total Liabilities is kr25.98 Mil as of Mar. 2026. The stock has 7 warning signs investors should review.

Cell Impact's Total Liabilities for the quarter that ended in Mar. 2026 was kr25.98 Mil.

Cell Impact's quarterly Total Liabilities increased from Sep. 2025 (kr29.21 Mil) to Dec. 2025 (kr42.34 Mil) but then declined from Dec. 2025 (kr42.34 Mil) to Mar. 2026 (kr25.98 Mil).

Cell Impact's annual Total Liabilities declined from Dec. 2023 (kr78.56 Mil) to Dec. 2024 (kr42.17 Mil) but then increased from Dec. 2024 (kr42.17 Mil) to Dec. 2025 (kr42.34 Mil).


Cell Impact Total Liabilities Historical Data

* Premium members only.

The historical data trend for Cell Impact's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cell Impact Total Liabilities Chart

Cell Impact Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 96.10 77.17 78.56 42.17 42.34

Cell Impact Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.29 49.14 29.21 42.34 25.98

Cell Impact Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Cell Impact's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=35.367+(6.975+1.7763568394003E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=42.34

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=163.372-121.03
=42.34

Cell Impact's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=20.424+(5.558+-0.00099999999999767
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=25.98

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=148.117-122.136
=25.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of kr25.98 Mil mean?
Cell Impact (OSTO:CI) has a Total Liabilities of kr25.98 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cell Impact and its competitors.
Is Cell Impact's Total Liabilities too high?
Cell Impact's current Total Liabilities is kr25.98 Mil.
How does Cell Impact's Total Liabilities compare to CRS and ATI?
Cell Impact's Total Liabilities of kr25.98 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for an Industrial Products company?
A good Total Liabilities depends on the Industrial Products industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Cell Impact and its competitors. Cell Impact's current Total Liabilities is kr25.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Impact stock overvalued right now?
Based on GuruFocus' analysis, Cell Impact (OSTO:CI) is currently considered Modestly Overvalued. The stock's GF Value™ is kr0.06, compared to a current price of kr0.08 — trading 28% above its estimated fair value. The current Total Liabilities is kr25.98 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Cell Impact (OSTO:CI), the current Total Liabilities is kr25.98 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cell Impact Business Description

Other Exchanges ICL:Germany
Address Kallmossvagen 7A, Karlskoga, SWE, 691 52
Cell Impact develops and manufactures flow plates for fuel cells and electrolyzers using materials such as graphite, stainless steel, and titanium. The company has developed and patented a high-velocity forming method, known as Cell Impact Forming, which enables the production of flow plates with advanced designs. Geographically, it operates in Sweden, Asia, the U.S., and Other Europe. It generates the majority of its revenue from Sweden.